Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.61 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.61 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.61 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 6/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29439786 | 1.00 | TDP1 (0.61) | TDP1CYP3A4ALDH1A1TSHRHPGD | |
| SCHEMBL4047380 | 0.83 | ALDH1A1 (0.43) | TDP1CYP3A4ALDH1A1TSHRHPGD | |
| SCHEMBL11188525 | 0.81 | ALDH1A1 (0.53) | TDP1CYP3A4ALDH1A1TSHRHPGD | |
| SCHEMBL18665461 | 0.81 | ALDH1A1 (0.53) | TDP1CYP3A4ALDH1A1TSHRHPGD | |
| SCHEMBL572768 | 0.79 | CYP3A4 (0.51) | TDP1CYP3A4ALDH1A1TSHRHPGD | |
| SCHEMBL573358 | 0.79 | ALDH1A1 (0.51) | TDP1CYP3A4ALDH1A1TSHRHPGD | |
| SCHEMBL30788051 | 0.79 | ALDH1A1 (0.51) | TDP1CYP3A4ALDH1A1TSHRHPGD | |
| SCHEMBL10280706 | 0.79 | ALDH1A1 (0.51) | TDP1CYP3A4ALDH1A1TSHRHPGD | |
| SCHEMBL2371582 | 0.79 | ALDH1A1 (0.51) | TDP1CYP3A4ALDH1A1TSHRHPGD | |
| SCHEMBL30358860 | 0.79 | CYP3A4 (0.51) | TDP1CYP3A4ALDH1A1TSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 427 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115991873-A | Low-dielectric fluorinated aromatic polyimide film and preparation method thereof | 慧创(东莞)材料技术有限责任公司 | 2023-04-21 | — | — | CN | claimed |
| US-20190048024-A1 | SYNTHETIC PROCESSES AND INTERMEDIATES | TAXIS PHARMACEUTICALS, INC. (US) | 2019-02-14 | — | — | US | claimed |
| EP-3419967-A1 | SYNTHETIC PROCESSES AND INTERMEDIATES | Taxis Pharmaceuticals, Inc. (US) | 2019-01-02 | — | — | EP | claimed |
| WO-2017147316-A1 | SYNTHETIC PROCESSES AND INTERMEDIATES | TAXIS PHARMACEUTICALS, INC. (US) | 2017-08-31 | — | — | WO | claimed |
| JP-5170742-A | — | — | None | — | — | JP | disclosed |
| JP-58170759-A | — | — | None | — | — | JP | disclosed |
| WO-2026106929-A1 | DIHYDROQUINAZOLINES USEFUL AS CYTOMEGALOVIRUS ANTIVIRAL AGENTS | ASSEMBLY BIOSCIENCES, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| US-12617789-B2 | Small molecular inhibitors of NF-κb inducing kinase | JANSSEN PHARMACEUTICA NV (BE) | 2026-05-05 | — | — | US | disclosed |
| US-12610730-B2 | Metal complex and light emitting device | CITY UNIVERSITY OF HONG KONG (HK) | 2026-04-21 | — | — | US | disclosed |
| US-20260103464-A1 | CYCLOPROPYL-(HETERO)ARYL-SUBSTITUTED ETHYLSULPHONYL-PYRIDINE DERIVATIVES | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2026-04-16 | — | — | US | disclosed |
| EP-4720055-A1 | CBL-B INHIBITORS AND METHODS OF USE THEREOF | Arcus Biosciences, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| EP-4705292-A1 | CBL-B INHIBITORS AND METHODS OF USE THEREOF | Arcus Biosciences, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-4831148-A | DIAZOTISING A 3-AMINO-2-HALOPYRIDINE IN PRESENCE OF HYDROGEN FLUORIDE | CIBA-GEIGY CORPORATION (US) | 1989-05-16 | — | — | US | disclosed |
| EP-0272824-A2 | Chemical compounds | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-06-29 | — | — | EP | disclosed |
| EP-0178260-A2 | Process for the preparation of fluorinated pyridine derivatives | CIBA-GEIGY AG (CH) | 1986-04-16 | — | — | EP | disclosed |
| JP-S58170759-A | 2-MERCAPTO-3-SUBSTITUTED-5-TRIFLUOROMETHYLPYRIDINE COMPOUND | ISHIHARA SANGYO KAISHA LTD | 1983-10-07 | — | — | JP | disclosed |
| US-4393212-A | ADRENERGIC BLOCKING AGENTS | MERCK & CO., INC. (US) | 1983-07-12 | — | — | US | disclosed |
| US-4294969-A | COUPLING N-BROMOSUCCINIMIDE AND A 2-BROMOPYRIDINE | MERCK & CO., INC. (US) | 1981-10-13 | — | — | US | disclosed |
| US-4279913-A | ANTIARRYTHMIA, HYPOTENSIVE | MERCK & CO., INC. (US) | 1981-07-21 | — | — | US | disclosed |
| EP-0003278-A1 | Polysubstituted-2-(3-loweralkylamino-2-R0-propoxy)pyridines, process for preparing the same, and pharmaceutical compositions containing the same | MERCK & CO. INC. (US) | 1979-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190048024-A1 | SYNTHETIC PROCESSES AND INTERMEDIATES | CYP11B1, CYP11B2, REN | TDP1 3664/4885CYP3A4 40/4885ALDH1A1 1693/4885 |
| US-12610730-B2 | Metal complex and light emitting device | OPRD1, OCIAD2, ORC3 | TDP1 1841/4885CYP3A4 737/4885ALDH1A1 4413/4885 |
| US-12617789-B2 | Small molecular inhibitors of NF-κb inducing kinase | IRAK3, IKBKB, IKBKG | TDP1 3147/4885CYP3A4 4654/4885ALDH1A1 3824/4885 |
| US-20260103464-A1 | CYCLOPROPYL-(HETERO)ARYL-SUBSTITUTED ETHYLSULPHONYL-PYRIDINE DERIVATIVES | CBR3, CYCS, CBR1 | TDP1 4527/4885CYP3A4 331/4885ALDH1A1 2267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.